|Daily Range||$18.30 - $19.03|
|52-Week Range||$8.42 - $29.79|
|Dividend (Yield)||$0.00 (0.0%)|
|Average Daily Volume||426,754|
|Current FY EPS||-$1.36|
Repros Therapeutics, Inc. (RPRX) Description
A biopharmaceutical company focused on the development of new drugs to treat hormonal and reproductive system disorders. Website: http://www.reprosrx.com/
Clinical data sends one stock up 137% on the week while a global pharmaceutical company announces three major collaborations ... in one day!
Pernix, Myriad, Repros and OraSure were four big winners in the biotech space during the past two days. Here's the back story on these pharmaceutical stock pops.
Repros shares soar after a favorable meeting with the Food and Drug Administration. Should shareholders applaud this latest news?